Vol 24, No 6 (2019)
Original research articles
Published online: 2019-11-01

open access

Page views 163
Article views/downloads 246
Get Citation

Connect on Social Media

Connect on Social Media

Biological dose-enhancement analysis with Monte Carlo simulation for Lipiodol for photon beams

Daisuke Kawahara1, Shuichi Ozawa12, Hisashi Nakano3, Katsumaro Kubo4, Takehiro Shiinoki5, Tomoki Kimura1, Yasushi Nagata12
DOI: 10.1016/j.rpor.2019.10.006
Rep Pract Oncol Radiother 2019;24(6):681-687.

Abstract

Background

Previously, the physical dose-enhancement factor (DphysEF) enhancement was introduced. However, the dose enhancement considering the biological effectiveness was not shown.

Purpose

The aim of the current study was to evaluate the biological dose-enhancement factor (DbioEF) by the dose rate and to compare the DphysEF and the DbioEF in Lipiodol for liver Stereotactic Body Radiation Therapy (SBRT).

Materials and methods

Flattening-filter-free (FFF) 6-MV (6MVX) and 10MVX beams were delivered by TrueBeam. A virtual inhomogeneity phantom and a liver SBRT patient-treatment plan were used. The DphysEF and lineal energy distribution ([[mml:math altimg="si8.gif"]][[mml:mi]]y[[/mml:mi]][[/mml:math]]) distribution was calculated from Monte Carlo simulations. Using a microdosimetric-kinetic (MK) model that is estimated based on the linear-quadratic formula for Lipiodol using human liver hepatocellular cells (HepG2), the biological dose and biological dose enhancement factor (DbioEF) were calculated. The dose rate in the simulation was changed from 0.1 to 24Gy/min.

Results

The DbioEF (DR:2Gy/min) and DphysEF with 10MVX FFF beam were 23.2% and 19.1% at maximum and 12.8% and 11.1% on average in the Lipiodol. In the comparison of the DbioEF between 0.1–24Gy/min, the DbioEF was 21.2% and 11.1% with 0.1Gy/min for 6MVX and 10 MVX, respectively. The DbioEF was larger than DEF for the 6MVX and 10MVX FFF beams. In clinical cases with the 10MVX FFF beam, the DbioEF and DphysEF in the Lipiodol region can increase the in-tumor dose by approximately 11% and 10%, respectively, without increasing the dose to normal tissue.

Conclusions

The lower-energy and higher-dose-rate beams were contributed to the biological dose. The Lipiodol caused the enhancement of the physical dose and biological effectiveness.

Advances in knowledge

The biological dose enhancement (DbioEF) should be considered in the high-density material such as the Lipiodol.

Article available in PDF format

View PDF Download PDF file



Reports of Practical Oncology and Radiotherapy